These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 33276032

  • 1. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 2. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C.
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [Abstract] [Full Text] [Related]

  • 3. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V, Lövgren-Sandblom A, Benthin L, Lawrance D, Chambers J, Gurung V, Thornton J, Chappell L, Khan E, Dixon P, Marschall HU, Williamson C.
    PLoS One; 2014 Dec; 9(1):e83828. PubMed ID: 24421907
    [Abstract] [Full Text] [Related]

  • 4. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM, Marín JJ, Brites D.
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [Abstract] [Full Text] [Related]

  • 5. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 6. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 29; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F, Zhang L, He MM, Liu ZF, Gao BX, Wang XD.
    Curr Med Res Opin; 2014 Aug 29; 30(8):1529-35. PubMed ID: 24665980
    [Abstract] [Full Text] [Related]

  • 9. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D.
    Ann Hepatol; 2002 Aug 29; 1(1):20-8. PubMed ID: 15114292
    [Abstract] [Full Text] [Related]

  • 10. Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study.
    Guerra M, Montaño I, Haye MT, Toro V, Maiz N.
    Am J Perinatol; 2024 May 29; 41(S 01):e2964-e2969. PubMed ID: 37774745
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 29; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 12. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
    Fleminger J, Seed PT, Smith A, Juszczak E, Dixon PH, Chambers J, Dorling J, Williamson C, Thornton JG, Chappell LC.
    BJOG; 2021 May 29; 128(6):1066-1075. PubMed ID: 33063439
    [Abstract] [Full Text] [Related]

  • 13. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B, Özler S.
    Hepatobiliary Pancreat Dis Int; 2020 Jun 29; 19(3):271-276. PubMed ID: 31919038
    [Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E.
    Hepatology; 2001 Mar 29; 33(3):504-8. PubMed ID: 11230728
    [Abstract] [Full Text] [Related]

  • 15. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C.
    Lancet; 2019 Mar 02; 393(10174):899-909. PubMed ID: 30773280
    [Abstract] [Full Text] [Related]

  • 16. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J.
    Hepatology; 1997 Dec 02; 26(6):1573-9. PubMed ID: 9398000
    [Abstract] [Full Text] [Related]

  • 17. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A, Marschall HU, Lammert F, Mattsson LA.
    Hepatology; 2005 Dec 02; 42(6):1399-405. PubMed ID: 16317669
    [Abstract] [Full Text] [Related]

  • 18. Impaired fetal myocardial deformation in intrahepatic cholestasis of pregnancy.
    Fan X, Zhou Q, Zeng S, Zhou J, Peng Q, Zhang M, Ding Y.
    J Ultrasound Med; 2014 Jul 02; 33(7):1171-7. PubMed ID: 24958403
    [Abstract] [Full Text] [Related]

  • 19. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
    Mikucka-Niczyporuk A, Pierzynski P, Lemancewicz A, Kosinski P, Charkiewicz K, Knas M, Kacerovsky M, Blachnio-Zabielska A, Laudanski P.
    Prostaglandins Other Lipid Mediat; 2020 Apr 02; 147():106399. PubMed ID: 31733339
    [Abstract] [Full Text] [Related]

  • 20. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, Smith S, Iqbal SN.
    Am J Obstet Gynecol; 2015 Oct 02; 213(4):570.e1-8. PubMed ID: 26071912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.